Protein Binding Assay Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global protein binding assay market looks promising with opportunities in the pharmaceutical & biotechnology industry. The global protein binding assay market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are rising research and development activities in the pharmaceutical sector, increasing drug development activities, and growing pressure to reduce cost incurred in discovery and development of drugs.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein binding assay market report, please download the report brochure.
In this market, instrument is the fastest growing product type of protein binding assay, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the protein binding assay market are given below:
The study includes trends and forecast for the global protein binding assay market by product and service, technology, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
InstrumentKits & ReagentsServices
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Equilibrium DialysisUltrafiltrationUltracentrifugationOther Technologies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical & Biotechnology CompaniesContract Research OrganizationOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the protein binding assays companies profiled in this report include Merck, Thermo Fisher Scientific, GE Healthcare, Sovicell, Absorption Systems, HTdialysis, Eurofins Scientific, ADMEcell, 3B Pharmaceuticals, Biotium, and Danaher.
Lucintel forecasts that instruments will remain the fastest growing product and service segment over the forecast period due to rising demand for user-friendly instruments and automated systems for detection of protein binding.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to increasing protein binding studies for drug discovery & development and the rising focus on development of biologics.
North America will remain the largest region over the forecast period due to increasing research activities related to drug discovery and presence of major pharmaceutical and biotechnology companies in the region.
Features of the Global Protein Binding Assay Market
Market Size Estimates: Global protein binding assay market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global protein binding assay market size by various segments, such as product and service, technology, and end user in terms of value.Regional Analysis: Global protein binding assay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, technology, end user, and region for the global protein binding assay market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global protein binding assay market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein binding assay market by product & service (instrument, kits & reagents, and services), technology (equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies), end user (pharmaceutical & biotechnology companies, contract research organization, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein binding assay market?
Q.5 What are the business risks and threats to the global protein binding assay market?
Q.6 What are the emerging trends in this protein binding assay market and the reasons behind them?
Q.7 What are some changing demands of customers in this protein binding assay market?
Q.8 What are the new developments in this protein binding assay market? Which companies are leading these developments?
Q.9 Who are the major players in this protein binding assay market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this protein binding assay market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global protein binding assay market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Services (Instrument, Kits & Reagents, and Services), Technology (Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies), and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global protein binding assay market looks promising with opportunities in the pharmaceutical & biotechnology industry. The global protein binding assay market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are rising research and development activities in the pharmaceutical sector, increasing drug development activities, and growing pressure to reduce cost incurred in discovery and development of drugs.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global protein binding assay market report, please download the report brochure.
In this market, instrument is the fastest growing product type of protein binding assay, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the protein binding assay market are given below:
The study includes trends and forecast for the global protein binding assay market by product and service, technology, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
InstrumentKits & ReagentsServices
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Equilibrium DialysisUltrafiltrationUltracentrifugationOther Technologies
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical & Biotechnology CompaniesContract Research OrganizationOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the protein binding assays companies profiled in this report include Merck, Thermo Fisher Scientific, GE Healthcare, Sovicell, Absorption Systems, HTdialysis, Eurofins Scientific, ADMEcell, 3B Pharmaceuticals, Biotium, and Danaher.
Lucintel forecasts that instruments will remain the fastest growing product and service segment over the forecast period due to rising demand for user-friendly instruments and automated systems for detection of protein binding.
Within this market, pharmaceutical and biotechnology companies will remain the largest segment by end user over the forecast period due to increasing protein binding studies for drug discovery & development and the rising focus on development of biologics.
North America will remain the largest region over the forecast period due to increasing research activities related to drug discovery and presence of major pharmaceutical and biotechnology companies in the region.
Features of the Global Protein Binding Assay Market
Market Size Estimates: Global protein binding assay market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global protein binding assay market size by various segments, such as product and service, technology, and end user in terms of value.Regional Analysis: Global protein binding assay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, technology, end user, and region for the global protein binding assay market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global protein binding assay market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global protein binding assay market by product & service (instrument, kits & reagents, and services), technology (equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies), end user (pharmaceutical & biotechnology companies, contract research organization, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global protein binding assay market?
Q.5 What are the business risks and threats to the global protein binding assay market?
Q.6 What are the emerging trends in this protein binding assay market and the reasons behind them?
Q.7 What are some changing demands of customers in this protein binding assay market?
Q.8 What are the new developments in this protein binding assay market? Which companies are leading these developments?
Q.9 Who are the major players in this protein binding assay market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this protein binding assay market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global protein binding assay market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Services (Instrument, Kits & Reagents, and Services), Technology (Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies), and End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Protein Binding Assay Market Trends and Forecast
3.3: Global Protein Binding Assay Market by Product and Service
3.3.1: Instrument
3.3.2: Kits & Reagents
3.3.3: Services
3.4: Global Protein Binding Assay Market by Technology
3.4.1: Equilibrium Dialysis
3.4.2: Ultrafiltration
3.4.3: Ultracentrifugation
3.4.4: Other Technologies
3.5: Global Protein Binding Assay Market by End User
3.5.1: Pharmaceutical & Biotechnology Companies
3.5.2: Contract Research Organization
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Protein Binding Assay Market by Region
4.2: North American Protein Binding Assay Market
4.2.1: Market by Product: Instrument, Kits & Reagents, and Services
4.2.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.2.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.2.4: The United States Protein Binding Assay Market
4.2.5: The Canadian Protein Binding Assay Market
4.2.6: The Mexican Protein Binding Assay Market
4.3: European Protein Binding Assay Market
4.3.1: Market by Product: Instrument, Kits & Reagents, and Services
4.3.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.3.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.3.4: The Protein Binding Assay Market of United Kingdom
4.3.5: The German Protein Binding Assay Market
4.3.6: The French Protein Binding Assay Market
4.4: APAC Protein Binding Assay Market
4.4.1: Market by Product: Instrument, Kits & Reagents, and Services
4.4.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.4.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.4.4: The Chinese Protein Binding Assay Market
4.4.5: The Indian Protein Binding Assay Market
4.4.6: The Japanese Protein Binding Assay Market
4.5: ROW Protein Binding Assay Market
4.5.1: Market by Product: Instrument, Kits & Reagents, and Services
4.5.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.5.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.5.4: Brazilian Protein Binding Assay Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Protein Binding Assay Market by Product and Service
7.1.2: Growth Opportunities for the Global Protein Binding Assay Market by Technology
7.1.3: Growth Opportunities for the Global Protein Binding Assay Market by End User
7.1.4: Growth Opportunities for the Global Protein Binding Assay Market by Region
7.2: Emerging Trends in the Global Protein Binding Assay Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Protein Binding Assay Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Protein Binding Assay Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Therm Fisher Scientific, Inc.
8.3: GE Healthcare
8.4: Sovicell GmbH
8.5: Absorption Systems LLC
8.6: HTdialysis
8.7: Eurofins Scientific, Inc.
8.8: ADMEcell, Inc.
8.9: 3B Pharmaceuticals
8.10: Biotium, Inc.
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Protein Binding Assay Market Trends and Forecast
3.3: Global Protein Binding Assay Market by Product and Service
3.3.1: Instrument
3.3.2: Kits & Reagents
3.3.3: Services
3.4: Global Protein Binding Assay Market by Technology
3.4.1: Equilibrium Dialysis
3.4.2: Ultrafiltration
3.4.3: Ultracentrifugation
3.4.4: Other Technologies
3.5: Global Protein Binding Assay Market by End User
3.5.1: Pharmaceutical & Biotechnology Companies
3.5.2: Contract Research Organization
3.5.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Protein Binding Assay Market by Region
4.2: North American Protein Binding Assay Market
4.2.1: Market by Product: Instrument, Kits & Reagents, and Services
4.2.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.2.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.2.4: The United States Protein Binding Assay Market
4.2.5: The Canadian Protein Binding Assay Market
4.2.6: The Mexican Protein Binding Assay Market
4.3: European Protein Binding Assay Market
4.3.1: Market by Product: Instrument, Kits & Reagents, and Services
4.3.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.3.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.3.4: The Protein Binding Assay Market of United Kingdom
4.3.5: The German Protein Binding Assay Market
4.3.6: The French Protein Binding Assay Market
4.4: APAC Protein Binding Assay Market
4.4.1: Market by Product: Instrument, Kits & Reagents, and Services
4.4.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.4.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.4.4: The Chinese Protein Binding Assay Market
4.4.5: The Indian Protein Binding Assay Market
4.4.6: The Japanese Protein Binding Assay Market
4.5: ROW Protein Binding Assay Market
4.5.1: Market by Product: Instrument, Kits & Reagents, and Services
4.5.2: Market by Technology: Equilibrium Dialysis, Ultrafiltration, Ultracentrifugation, and Other Technologies
4.5.3: Market by End User: Pharmaceutical & Biotechnology Companies, Contract Research Organization, and Others
4.5.4: Brazilian Protein Binding Assay Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Protein Binding Assay Market by Product and Service
7.1.2: Growth Opportunities for the Global Protein Binding Assay Market by Technology
7.1.3: Growth Opportunities for the Global Protein Binding Assay Market by End User
7.1.4: Growth Opportunities for the Global Protein Binding Assay Market by Region
7.2: Emerging Trends in the Global Protein Binding Assay Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Protein Binding Assay Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Protein Binding Assay Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Therm Fisher Scientific, Inc.
8.3: GE Healthcare
8.4: Sovicell GmbH
8.5: Absorption Systems LLC
8.6: HTdialysis
8.7: Eurofins Scientific, Inc.
8.8: ADMEcell, Inc.
8.9: 3B Pharmaceuticals
8.10: Biotium, Inc.
